eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
2/2024
vol. 10
 
Share:
Send email
Share:
abstract:
Original paper

Assessment of serum Mac-2 binding protein glycosylation isomer as a potential marker for hepatocellular carcinoma in cirrhotic hepatitis C patients

Mohamed Gamal
1
,
Khaled Moheyeldin
1
,
Mona Wagdy
2
,
Nada Aposhady
1
,
Aly Elkady

  1. Department of Tropical Medicine, Faculty of Medicine, University of Alexandria, Egypt
  2. Department of Chemical and Clinical Pathology, Faculty of Medicine, University of Alexandria, Egypt
Clin Exp HEPATOL 2024; 10, 2: 90-97
DOI: https://doi.org/10.5114/ceh.2024.139981
Online publish date: 2024/06/18
View full text Get citation
 
PlumX metrics:
Aim of the study:
To assess the serum level of Mac-2 binding protein glycosylation isomer as a potential biomarker for hepatocellular carcinoma (HCC) in hepatitis C virus (HCV) cirrhotic patients.

Material and methods:
Ninety patients were separated into two groups for the current research. Group I consisted of 45 patients with HCV that resulted in liver cirrhosis but no HCC. Group II consisted of 45 patients who had HCC and hepatic cirrhosis caused by HCV. Each patient underwent a complete clinical examination, thorough history taking, and laboratory tests, serum Mac-2 BPGI, abdominal ultrasound and triphasic computed tomography (CT) of the liver.

Results:
Serum Mac-2 BPGI was significantly higher in group II than group I and was statistically significantly higher in patients with portal vein invasion and in patients with lymph node metastases than those without, there was a statistically significant difference between mean values of serum M2BPGI, the BCLC score was higher in group C, and also a significant positive relation between tumor size and serum M2BPGI was found.

Conclusions:
Serum Mac-2 BPGI can be used as diagnostic and prognostic markers for HCC.

keywords:

markers, carcinoma, cirrhosis, metastases, hepatitis
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.